Nanovaccine boosts immunity in sufferers of metabolic syndrome

(Cornell University) A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news